IMFL - ETF AI Analysis
Top Page
Invesco International Developed Dynamic Multifactor ETF (IMFL)
IMFL, the Invesco International Developed Dynamic Multifactor ETF, earns a solid overall rating largely because it holds high-quality global companies like Novartis, ASML, Investor AB, and TotalEnergies, which bring strong financial performance, solid balance sheets, and generally positive technical and valuation signals. The rating is held back somewhat by names such as Shell, BHP, and Roche, where short-term technical weakness, valuation concerns, and profitability or cash flow challenges introduce risk, and the fund’s meaningful exposure to large energy and materials companies adds sector-related volatility to its profile.
IMFL vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.11B
- Region
- Developed Markets
- Expense Ratio
- 0.34%
- Beta
- 0.67
- Issuer
- Invesco
- Inception Date
- Feb 24, 2021
- Dividend Yield
- 3.44%
- Asset Class
- Equity
- Index Tracked
- FTSE Developed ex US Invesco Dynamic Multifactor Index
IMFL Summary
IMFL is the Invesco International Developed Dynamic Multifactor ETF, which follows the FTSE Developed ex US Invesco Dynamic Multifactor Index. It invests in large, established companies from developed countries outside the U.S., including Japan, the UK, South Korea, and more. The fund holds well-known names like Samsung Electronics, ASML, Novartis, Shell, and Nestlé, and spreads money across many sectors such as industrials, health care, technology, and energy. Someone might invest in IMFL to diversify beyond the U.S. and seek long-term growth from global markets. A key risk is that international stocks can go up and down with global market and currency swings.
How much will it cost me?
This ETF has an expense ratio of 0.34%, which means you’ll pay about $3.40 per year for every $1,000 invested. That cost is a bit higher than many simple index ETFs because this fund uses a more complex, actively managed multifactor strategy to try to improve returns and manage risk.
What would affect this ETF?
This ETF focuses on developed markets outside the U.S., so it could benefit if global growth improves, technology and health care companies like Samsung, ASML, Novartis, and Roche continue to innovate, and its multifactor approach helps it adapt well to changing market conditions. On the downside, slower economic growth abroad, falling demand for electronics or commodities, changes in energy regulations affecting companies like Shell and BHP, or rising interest rates that pressure financial and industrial stocks could hurt performance.
IMFL Top 10 Holdings
IMFL leans heavily on a mix of global chipmakers and defensive blue chips to drive returns. ASML and Samsung are key tech anchors, with ASML rising but showing mixed momentum, while SK hynix has been lagging lately and quietly weighs on performance. On the defensive side, Novartis and Roche are steady climbers, giving the fund a solid health care backbone, and Nestlé adds stability despite more mixed recent trading. Energy names like Shell and TotalEnergies are also rising, helping balance the portfolio. Overall, it’s a diversified, developed-markets ex‑U.S. play with no single stock dominating the story.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 KR:005930 | Samsung Electronics | 4.21% | $46.02M | KRW 1432.08T | 116.14% | ―― |
 NL:ASML | ASML Holding NV | 2.37% | $25.92M | EUR 539.67B | 50.70% | 76Outperform |
 CH:NOVN | Novartis AG | 2.46% | $26.86M | CHF 244.89B | 35.30% | 80Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 KR:000660 | SK hynix Inc. | 1.93% | $21.09M | KRW 1033.53T | 149.65% | ―― |
 GB:SHEL | Shell (UK) | 1.72% | $18.80M | GBP 229.30B | 40.01% | 73Outperform |
 CH:NESN | Nestlé SA | 1.64% | $17.98M | CHF 217.87B | 9.36% | 71Outperform |
 AU:BHP | BHP Group Ltd | 1.37% | $15.01M | AUD 292.61B | 31.18% | 68Neutral |
 SE:INVE.B | Investor AB | 1.37% | $15.02M | SEK 1.30T | 35.01% | 77Outperform |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
IMFL Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IMFL, the sentiment is Neutral. The current price of 33.54 is above the 20-day moving average (MA) of 33.38, below the 50-day MA of 33.83, and above the 200-day MA of 33.05, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 49.87 is Neutral, neither overbought nor oversold. The STOCH value of 59.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IMFL.
IMFL Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| IMFL | $33.54 | $35.00(4.35% Upside) | $1.11B | 0.34% | 60Neutral |
 LVHI | $43.18 | $47.12(9.12% Upside) | $6.39B | 0.40% | 67Neutral |
 GSIE | $46.15 | $55.97(21.27% Upside) | $5.98B | 0.25% | 65Neutral |
 IMTM | $50.96 | $63.65(24.90% Upside) | $4.26B | 0.30% | 69Neutral |
 IDMO | $58.01 | $71.53(23.31% Upside) | $4.26B | 0.25% | 71Outperform |
 INTF | $41.19 | $49.29(19.67% Upside) | $3.73B | 0.16% | 64Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IMFL | Invesco International Developed Dynamic Multifactor ETF | 33.54 | 5.59 | 19.98% | |
| LVHI | Legg Mason International Low Volatility High Dividend ETF | 43.18 | 9.47 | 28.09% | |
| GSIE | Goldman Sachs ActiveBeta International Equity ETF | 46.15 | 5.86 | 14.55% | |
| IMTM | iShares MSCI Intl Momentum Factor ETF | 50.96 | 5.28 | 11.56% | |
| IDMO | Invesco S&P International Developed Momentum ETF | 58.01 | 6.05 | 11.65% | |
| INTF | iShares MSCI Intl Multifactor ETF | 41.19 | 5.91 | 16.75% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.